Literature DB >> 2299857

Risk stratification and long-term results after surgical treatment of carcinomas of the thoracic esophagus and cardia. A 25-year retrospective study.

O Lund1, H H Kimose, M T Aagaard, J M Hasenkam, M Erlandsen.   

Abstract

During 25 years (1960 to 1984), 657 patients (aged 22 to 91, mean 66 years) were operated on for carcinomas (squamous cell, n = 230; adenocarcinoma, n = 399; anaplastic, n = 28) of the thoracic esophagus (n = 347) or gastric cardia (n = 310). Esophagogastrectomy was accomplished in 514 patients, of whom 94% (n = 481) had an "inkwell" esophagogastrostomy performed. The hospital mortality rate (less than or equal to 30 days) was 19% and the 5-year cumulative survival rate was 9% +/- 1% (standard error). A Cox regression analysis enabled a detailed risk stratification of the patients. T, N, and M class and age were the strongest predictor variables. The general status of the patients, including pulmonary disease, also had a strong prognostic influence. Eight risk groups were identified having 1-year and 5-year survival rates of 71%/41% (n = 35), 69%/24% (n = 80), 47%/11% (n = 125), 30%/6% (n = 139), 12%/0% (n = 105), 6%/0% (n = 71), 2%/0% (n = 57), and 0%/0% (n = 45) (p less than 0.0001). Hospital mortality (from 6% to 42%) and complication rates increased significantly from the low-risk to high-risk groups. Comparisons with survival rates of background populations matched to each of the first four risk groups indicated that the benefit of surgical treatment may be underestimated if only patient survivals are judged. Use of modern endoscopic and noninvasive tests may yield a reliable TNM classification without surgical exploration. Given the extremely poor prognostic outlook together with high hospital mortality and complication rates of the four last risk groups, an aggressive surgical approach with resection whenever possible can no longer be regarded rational. Selection for surgical treatment should be based on a detailed risk estimation that takes into account both TNM classification and general patient status.

Entities:  

Mesh:

Year:  1990        PMID: 2299857

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  Impact of perioperative peripheral blood values on postoperative complications after esophageal surgery.

Authors:  Hiroshi Saeki; Takanobu Masuda; Satoko Okada; Koji Ando; Masahiko Sugiyama; Keiji Yoshinaga; Kazuya Endo; Noriaki Sadanaga; Yasunori Emi; Yoshihiro Kakeji; Masaru Morita; Natsumi Yamashita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-06-26       Impact factor: 2.549

Review 2.  Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.

Authors:  Panagiotis Tsibouris; Erasmia Vlachou; Peter Edward Thomas Isaacs
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

3.  Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.

Authors:  Ines Gockel; Kathrin Dirksen; Claudia-M Messow; Theodor Junginger
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

4.  Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?

Authors:  Y Tabira; T Okuma; K Kondo; M Yoshioka; T Mori; M Tanaka; K Nakano; N Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-08

5.  Analysis of reduced death and complication rates after esophageal resection.

Authors:  B P Whooley; S Law; S C Murthy; A Alexandrou; J Wong
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

6.  Pulmonary Complications due to Esophagectomy.

Authors:  Abulfazl Shirinzadeh; Yashar Talebi
Journal:  J Cardiovasc Thorac Res       Date:  2011-08-20

7.  Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus.

Authors:  R C Fitzgerald; I T Saeed; D Khoo; M J Farthing; W R Burnham
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

Review 8.  Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Thomas M Runge; Julian A Abrams; Nicholas J Shaheen
Journal:  Gastroenterol Clin North Am       Date:  2015-04-09       Impact factor: 3.806

9.  Comparison of uptake characteristics and prognostic value of 201Tl and 18F-FDG in esophageal cancer.

Authors:  Hyun Woo Chung; Kyung-Han Lee; Eun Jeong Lee; Su Jin Lee; Young Seok Cho; Joon Young Choi; Young Mog Shim; Kwhanmien Kim; Byung-Tae Kim
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

10.  Outcomes following oesophagectomy in patients with oesophageal cancer: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Daniel P Park; Catherine A Welch; David A Harrison; Thomas R Palser; David A Cromwell; Fang Gao; Derek Alderson; Katherine M Rowan; Gavin D Perkins
Journal:  Crit Care       Date:  2009       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.